Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Genix Pharmaceuticals ( (TSE:GENX) ) has shared an announcement.
Genix Pharmaceuticals has issued a clarification regarding a previous announcement about its non-brokered private placement. The company corrected the unit price from $0.10 to $0.05, resulting in the issuance of 2,000,000 units for total gross proceeds of $100,000. Each unit includes one common share and one warrant, allowing the purchase of an additional share at $0.10 within two years. This clarification ensures accurate information for stakeholders and maintains transparency in the company’s financial transactions.
More about Genix Pharmaceuticals
Genix Pharmaceuticals Corporation is a Canadian company specializing in ophthalmic drugs. It focuses on the research, development, manufacture, licensing, and sales of innovative prescription and over-the-counter ophthalmological products, catering to the global market and particularly targeting the aging baby boomer demographic. The company has several products pending approval from Health Canada.
Average Trading Volume: 168,000
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$1.78M
For detailed information about GENX stock, go to TipRanks’ Stock Analysis page.